Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-TNF-anti-IL-17 bispecific antibodies

Anti-TNF-anti-IL-17 bispecific antibodies

US Patent 9416182 · Granted Aug 16, 2016

Estimated economic value: $251,883,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Underwater ducted hydroelectric power generation system2025
Glucocorticoid receptor agonists2025
PAN-ELR+ CXC chemokine antibodies for the treatment of hidradenitis suppurativa2024
Human interleukin-4 receptor alpha antibodies2024
Anti-human CD19 antibodies2023
Ducted double-magnetic-circuit coreless motor special for electric aircraft2022
BTLA agonist antibodies and uses thereof2022
CD200R agonist antibodies and uses thereof2022
Rare-earth permanent-magnetic axial coreless generator with double magnetic circ2022
Anti-N3pGlu amyloid beta peptide antibodies and uses thereof2021
Anti-N3pGlu amyloid beta peptide antibodies and uses thereof2021
Ducted and balanced wind turbine2020